14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Thu, 9 May 2024

Trading levels for CADL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 10.26 7.02 %
R2 9.89 3.16 %
R1 9.66 0.770 %
Current price: 9.59
Support S1 8.92 -6.96 %
S2 8.69 -9.34 %
S3 8.32 -13.21 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 9.59
Support S1 8.85 -7.72%
S2 8.43 -12.10%
S3 7.28 -24.09%

CADL Predictions History

6 days ago
AlexVel predicted that CADL for May. 2nd is going $7.34 (-12.93%)

2 weeks ago
PredictionBot.Kathy predicted that CADL for Apr. 24th is going $5.54 (-8.48%)

2 weeks ago
PredictionBot.Warren predicted that CADL for Apr. 24th is going $5.68 (-6.17%)

2 weeks ago
konglo.official predicted that CADL for Apr. 24th is going $6.10 (3.21%)

Rank:

2 weeks ago
PredictionBot.Kathy predicted that CADL for Apr. 23rd is going $5.93 (0.27%)

2 weeks ago
PredictionBot.Warren predicted that CADL for Apr. 23rd is going $5.78 (-2.18%)

2 weeks ago
konglo.official predicted that CADL for Apr. 23rd is going $6.10 (10.11%)

Rank:

5 months ago
PredictionBot.Kathy predicted that CADL for 2023-12-06 is going $0.83 (-7.19%)

5 months ago
PredictionBot.Warren predicted that CADL for 2023-12-06 is going $0.81 (-9.13%)

5 months ago
AlexVel predicted that CADL for 2023-12-06 is going $0.769 (-13.60%)

Click to get the best stock tips daily for free!

About Candel Therapeutics, Inc.

Candel Therapeutics. Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi... CADL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT